MARATTO

article · SVU-International Journal of Medical Sciences

The Possible Association between Diabetes Mellitus and Pseudoexfoliation Syndrome in Egyptian Population

2024Open accessAssiut University

Abstract

Background: Unknown is the precise chemical make-up of the fibrillar substance. It is believed that it is secreted multifocally by the ciliary epithelium, iris pigment epithelium, and peripheral anterior lens epithelium. Pseudoexfoliation syndrome has been associated with ischemic heart disease (IHD), arterial hypertension(AH), and type 2 diabetes. Certain illnesses, such as pseudoexfoliation, may be more common in people with diabetes mellitus. Diabetic patients had a higher prevalence of PEX than people without diabetes, according to Psilas. Objectives: to determine the relationship between diabetes mellitus and pseudoexfoliation syndrome.Patient and methods: The ophthalmology department at Qena University Hospital was the site of this study. The patients were divided into two groups.Results: A PXF diagnosis was associated with a significantly higher probability of DM. In terms of Binary Logistic Regression, pseudoexfoliation and DM displayed a significant correlation.Conclusion: There was a strong correlation between pseudoexfoliation syndrome and diabetes mellitus. Patients diagnosed with PXF are 4.6 times more likely to be diabetic than subjects with no PXF.

Research topics

  • Skin Diseases and Diabetes
  • Systemic Sclerosis and Related Diseases
  • Cardiovascular Function and Risk Factors

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/svuijm.2023.195917.1541

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.